T Cell Assays and MIATA: The Essential Minimum for Maximum Impact
Cedrik M. Britten(Johannes Gutenberg University Mainz), Mark M. Davis(Stanford Medicine), Steffen Walter(Universität Ulm), Kunle Odunsi(University of Chicago), Lisa H. Butterfield(Merck & Co., Inc., Rahway, NJ, USA (United States)), Graham Pawelec(Health Sciences North), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Michael Kalos(Pillar College), Bart O. Roep(Immune Regulation (United Kingdom)), Jill O’Donnell-Tormey(Cancer Research Institute), Sjoerd H. van der Burg(Leiden University Medical Center), Sylvia Janetzki(Yale University), Guido Ferrari(Duke University), Holden T. Maecker(Stanford University), Christian H. Ottensmeier(Clatterbridge Cancer Centre NHS Foundation Trust), Axel Hoos(GlaxoSmithKline (United States)), Lloyd J. Old(Gynecologic Oncology Group), Mario Roederer(National Institutes of Health), Pedro Romero(TiGenix (Spain)), Christian G. Huber(University of Salzburg), Cécile Gouttefangeas(University of Tübingen), H. I. Levitsky(Johns Hopkins University), Tom H. M. Ottenhoff(Office of Infectious Diseases)
Cited by 131
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k